Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy

PURPOSE: To study the impact of adjuvant trastuzumab among patients achieving a pathologic complete response (pCR) after trastuzumab-based neoadjuvant systemic therapy (NST). PATIENTS AND METHODS: Patients with primary HER2-positive breast cancer treated with trastuzumab-based NST were categorised a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Angulo, A M, Parinyanitikul, N, Lei, X, Mittendorf, E A, Zhang, H, Valero, V, Hunt, K K, Hortobagyi, G N, Chavez-MacGregor, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333494/
https://www.ncbi.nlm.nih.gov/pubmed/25584488
http://dx.doi.org/10.1038/bjc.2014.647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333494/
https://www.ncbi.nlm.nih.gov/pubmed/25584488
http://dx.doi.org/10.1038/bjc.2014.647

Ejemplares similares